TARGETING C-REL O-GLCNACYLATION AND USES THEREOF
    2.
    发明申请
    TARGETING C-REL O-GLCNACYLATION AND USES THEREOF 有权
    目标C-O O-GLCNACYLATION及其用途

    公开(公告)号:US20140212876A1

    公开(公告)日:2014-07-31

    申请号:US14166681

    申请日:2014-01-28

    Abstract: Serine 350 has been identified as the site of O-GlycNAcylation of c-Rel. Methods are provided for identifying compositions capable of blocking c-Rel activation. The methods generally involve identifying compounds that inhibit O-GlcNAcylation of c-Rel at the serine 350 residue, thereby preventing c-Rel activation and production of c-Rel-dependent cytokines.

    Abstract translation: 丝氨酸350已经被鉴定为c-Rel的O-糖基化的位点。 提供了用于鉴定能够阻断c-Rel活化的组合物的方法。 所述方法通常涉及鉴定在丝氨酸350残基处抑制c-Rel的O-GlcNAc化的化合物,从而防止c-Rel活化并产生c-Rel依赖性细胞因子。

Patent Agency Ranking